You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tumor profile

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocarcinoma, Pancreatic Tumor Trial in Clichy (Hepatocellular carcinoma, Pancreatic adenocarcinoma, Pancreatic

Recruiting
  • Hepatocarcinoma
  • Pancreatic Tumor
  • Hepatocellular carcinoma
  • +2 more
  • Clichy, France
    Hôpital Beaujon
Mar 20, 2023

Evidence Determining Individualized Cancer Therapy for Incurable

Terminated
  • Hematologic Cancer
  • Molecularly targeted treatment matched to genomic/immunophenotypic tumor profile (chosen by treating physician)
  • La Jolla, California
    UCSD Moore's Cancer Center
Jan 31, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (Best Practice, Chart

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Best Practice
  • +6 more
  • (no location specified)
Jul 12, 2022

Gut and Tumor Microbiome in Advanced ER-positive and

Not yet recruiting
  • Breast Cancer
  • Melanoma
  • Observation
  • (no location specified)
Nov 6, 2023

Solid Tumor Trial in Beijing (Hemay181)

Not yet recruiting
  • Solid Tumor
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Feb 27, 2023

Tumors Trial in France (Blood and tumor samples)

Recruiting
  • Neoplasms
  • Blood and tumor samples
  • Annecy, France
  • +5 more
Apr 8, 2022

Advanced Solid Tumor Trial in Beijing (Simmitinib, SG001)

Not yet recruiting
  • Advanced Solid Tumor
  • Beijing, Beijing, China
    Cancer Hospital,Chinese Academy of Medical Sciences and Peking U
Nov 9, 2023

Advanced Solid Tumor Trial in Navi Mumbai (MSP008-22)

Not yet recruiting
  • Advanced Solid Tumor
  • Navi Mumbai, Maharashtra, India
    Advanced Centre for Treatment, Research and Education in Cancer
Jul 25, 2022

Molecular Services and EMR-Lab Integration Application for

Not yet recruiting
  • Advanced Cancer
  • +2 more
  • Comprehensive Genomic Profile testing; ELIA software; Molecular Genetic Pathologist consultation
  • limited genetic testing or no testing
  • Rock Hill, South Carolina
    Carolina Blood and Cancer Care Associates
Oct 18, 2023

Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma Trial in Shanghai (Phase I

Not yet recruiting
  • Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
  • Phase I dose escalation
  • +3 more
  • Shanghai, Shanghai, China
    Fudan Cancer Hospital
Apr 24, 2023

Ewing's Sarcoma Trial in United States (Vigil, Temozolomide, Irinotecan)

Completed
Has Results
  • Ewing's Sarcoma
  • Vigil
  • +4 more
  • Little Rock, Arkansas
  • +5 more
Dec 20, 2022

Spectroscopic Analysis of Tongue Tumor Samples.

Recruiting
  • Mass Spectroscopy
  • +5 more
  • tongue surgery
  • Amiens, Picardie, France
    Centre Hospitalier Universitaire d'Amiens
Nov 2, 2021

Cancer, Advanced Cancer, Advanced Solid Tumor Trial (Drug-Drug Interaction Profile, Drug-Gene Interaction Profile, Standard of

Not yet recruiting
  • Cancer
  • +2 more
  • Drug-Drug Interaction Profile
  • +2 more
  • (no location specified)
Dec 8, 2021

NSCLC Trial in Washington, Hackensack, Neptune (Nivolumab, Ipilimumab, Carboplatin)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Washington, District of Columbia
  • +2 more
Jan 27, 2023

Solid Tumor Trial in Buffalo (entolimod, pharmacological study, laboratory biomarker analysis)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Mediated

Recruiting
  • HPV-Associated Oropharyngeal Squamous Cell Carcinoma
  • +11 more
  • NavDx HPV ctDNA Testing
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jul 6, 2022

Malignant Solid Tumors, Primary Brain Tumor, Melanoma Trial in Saint Petersburg

Recruiting
  • Malignant Solid Tumors
  • +6 more
    • Saint Petersburg, Russian Federation
      N.N. Petrov NMRC of Oncology, Oncoimmunology dep.
    Sep 13, 2022

    Solid Tumor Trial in Shanghai (HB002.1T)

    Completed
    • Solid Tumor
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Jul 26, 2021

    Recurrent DLBCL, Refractory DLBCL Trial in Houston (Chemotherapy, Computed Tomography, Fludeoxyglucose F-18)

    Completed
    • Recurrent Diffuse Large B-Cell Lymphoma
    • Refractory Diffuse Large B-Cell Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 27, 2022

    Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

    Recruiting
    • Advanced Cancer
    • Solid Tumor
    • Helsinki, Uusimaa, Finland
    • +2 more
    Jun 8, 2022

    (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of

    Recruiting
    • Colorectal Neoplasms
      • Maastricht, Limburg, Netherlands
        Maastricht UMC+
      Jan 10, 2023

      From Non-Hematologic Cancer for Use in Development ofLiquid

      Recruiting
      • Non-hematologic Cancer
        • Riverside, California
          Compassionate Care Research Group, Inc.
        Sep 16, 2021

        Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma Trial in Belgium, United States (Bapotulimab (BAY1905254),

        Active, not recruiting
        • Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma
        • Bapotulimab (BAY1905254)
        • Bapotulimab (BAY1905254) + Pembrolizumab
        • Tucson, Arizona
        • +7 more
        Jan 12, 2023

        Advanced Solid Tumors, NSCLC Trial in Israel, United States (BAY2862789)

        Not yet recruiting
        • Advanced Solid Tumors
        • Non-small Cell Lung Cancer
        • Detroit, Michigan
        • +5 more
        May 5, 2023

        Metastatic Melanoma and Other Solid Tumors Trial in United States (BAY2666605)

        Active, not recruiting
        • Metastatic Melanoma and Other Solid Tumors
        • Nashville, Tennessee
        • +2 more
        Feb 1, 2023